One surprising fact in DBS technology is that the human A surgical treatment for Parkinson's disease. A special wire (lead) is inserted into a specific area of the brain responsible for movement. The lead is connected to a pacemaker-like device implanted in the chest region.
National Parkinson Foundation's blog
Finding the right exercise program is extremely important for PD which is characterized by movement disorders such as slow or shuffling walk, tremors in the hands, fingers, forearms, feet, mouth, or chin, rigid or stiff muscles, including muscles that suddenly freeze for no reason, muscle pain and unsteady gait and balance.
Recently there has been a surge of interest in cholesterol and cholesterol lowering drugs (statins) and the risk of developing Parkinson’s disease (PD). Patients and families with a personal interest in the outcomes of these studies simply want to know whether they should consider starting a statin medication or they should change their diet. In this month's What’s Hot column we will examine the evidence and offer a recommendation for those considering a statin drug.
One of the common dreams shared by Parkinson’s disease patients around the globe is the possibility of living a pill free existence, and one year ago we shared the news of a therapy coming to the United States with the possibility to make this a reality for a select group of patients. This month we will update the previous blog post from 2014, and bring to you all of the information you need to know about the therapy. The therapy has received a full FDA approval and
The What’s Hot in Parkinson’s disease blog written in April 2013 featured a new extended release A chemical messenger (neurotransmitter) that regulates movement and emotions. drug called IPX066. This new dopamine formulation achieved full FDA approval in January 2015. The drug is now sold under the name Rytary.
Dementia with Abnormal aggregation of proteins that develop inside nerve cells in people with Parkinson’s, named after Fritz Heinrich Lewy, the first person who noticed that some unusual proteins in the brain can make people act and think differently. Alpha-synuclein is the main component of Lewy bodies. (DLB) is a common progressive brain disease that affects thinking, movement, behavior and sleep.
Considerable evidence has been mounting supporting a relationship between the gastrointestinal system and Parkinson’s disease. Many pathologists and neurologists believe that Parkinson’s disease may start in the gut, however this view remains speculative. Additionally, there are many GI symptoms such as constipation that occur as prominent and disabling features of Parkinson’s disease.
In September 2012, the What’s Hot in Parkinson’s Disease? blog featured a new therapy that at that time had entered into human testing. The Austrian company AFFiRiS A.G.
Impulse control disorders including behaviors such as gambling, shopping, pathological eating and hypersexuality can occur in 1 out of every 6 people with Parkinson’s disease (PD) taking a A class of medications used to treat Parkinson's disease. Agonists enhance the activity of a neurotransmitter – in this case, dopamine.
There has been speculation that migraine headache syndromes may have an important relationship to Parkinson’s disease. Though most associations uncovered by research studies have been speculative, two interesting papers appeared in the literature in the past few months, and investigators around the world have now rekindled the question, could headaches be related to Parkinson’s disease?